Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-22-244817
Filing Date
2022-09-14
Accepted
2022-09-14 16:58:23
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-1/A d946432df1a.htm F-1/A 3352882
2 EX-23.1 d946432dex231.htm EX-23.1 1306
3 GRAPHIC g946432g02h00.jpg GRAPHIC 144898
4 GRAPHIC g946432g03a03.jpg GRAPHIC 21375
5 GRAPHIC g946432g03a20.jpg GRAPHIC 83369
6 GRAPHIC g946432g16p83.jpg GRAPHIC 148158
7 GRAPHIC g946432g66d00.jpg GRAPHIC 67346
8 GRAPHIC g946432g75w96.jpg GRAPHIC 124073
9 GRAPHIC g946432g83h25.jpg GRAPHIC 160095
10 GRAPHIC g946432g85u61.jpg GRAPHIC 114263
11 GRAPHIC g946432g86g86.jpg GRAPHIC 20379
  Complete submission text file 0001193125-22-244817.txt   4554497
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filer) CIK: 0001898416 (see all company filings)

EIN.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-266294 | Film No.: 221243553
SIC: 2836 Biological Products, (No Diagnostic Substances)